New Fund
Australia-based Brandon Capital closed its sixth fund at A$439 million to invest in emerging biomedical technologies and support the commercialisation of life sciences innovations.
Australia-based Ochre Ventures completed a $30 million first close on its...
Melbourne-based Boman Group has launched a $1 billion fund to back...
Stack Infrastructure secured AU$1.3bn in green financing to fund the next...
Latin America-focused Propel Venture Partners closed a $100M Fund V to...
<a href="https://brandonbiocatalyst.com">Brandon BioCatalyst</a>, <a...
Australia-based Goodman Group launched an AU$4.1 billion fund to invest in...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
